Quanterix has unveiled its Single Molecule Array (Simoa)technology, making it commercially available for the first time on a fullyautomated platform for research use only. With Simoa, life-science researcherswill be empowered to explore biomarkers and pathways with greater sensitivityand precision, paving the way for the development of new diagnostic tests andimproved treatment of diseases in oncology, neurology, cardiology and otherfields of medicine.